GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Purchase Of Investment

Bio-Techne (BSP:T1CH34) Purchase Of Investment : R$0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Bio-Techne Purchase Of Investment?

Bio-Techne's purchase of investment for the three months ended in Mar. 2025 was R$0 Mil. It means Bio-Techne spent R$0 Mil on purchasing investments. Bio-Techne's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was R$0 Mil.

Compared with last quarter (R$0 Mil in Dec. 2024 ), Bio-Techne spent the same money on purchasing investments in Mar. 2025 (R$0 Mil).

Bio-Techne Purchase Of Investment Historical Data

The historical data trend for Bio-Techne's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Purchase Of Investment Chart

Bio-Techne Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -364.16 -199.55 -393.71 -99.50 -29.76

Bio-Techne Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bio-Techne Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Techne Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Purchase Of Investment
Comparable Companies
RVMD ROIV HALO JAZZ BPMC BBIO CORT MDGL TGTX LEGN VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
TECH:USA
Address
614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Website
https://www.bio-techne.com
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne Headlines

No Headlines